Life Sciences & Pharmaceutical Companies

Life sciences and pharmaceutical companies face a unique set of operational and financial challenges, from conducting clinical trials to bringing products to market to expanding operations—all within a complex regulatory environment. The road to success and overcoming these challenges begins with forging strong relationships with accounting, tax, and consulting professionals with industry-specific expertise.

Who We Serve

Our Life Sciences Practice Group serves privately-owned companies from start-ups to large multinational and middle-market companies.  We have collaborated with organizations focused on many areas, including:

  • Generic drug manufacturers and distributors focused on injectables, pills, and capsules
  • Branded pharmaceuticals, including FDA 505(b)(2) focused organizations
  • Nutraceuticals
  • Organizations focused on clinical research and research and development

Our Expertise

Having spent significant time helping our clients navigate the complex accounting and tax issues prevalent in the life sciences industry, our capabilities include:

  • Calculation of gross to net sales and receivables, with hands-on experience with many aspects of the calculations including chargebacks, rebates, wholesaler fees, and group purchasing organizations
  • Determining proper accounting and tax treatment for payments received under research and development milestone agreements
  • Analyzing complex accounting treatment for joint ventures and collaboration agreements
  • Helping companies claim research and development tax credits and other tax incentives

Our Services

Accounting & Tax


  • R&D Credits
  • Financial modeling
  • Internal controls & entity policies
  • Financial reporting
  • IT/Computer consulting
  • Structure of employee compensation plans
  • Budgets and projections


  • Bank financing
  • Stock compensation and other equity compensation
  • Capital structures
  • Benefit plan services
  • 83(b) election
  • Angel investment
  • Venture Debt
  • Private equity investment


International Expansion

Exit Planning

Our Life Sciences team.

Chris Frederick

Pharmaceutical Management Certified